AngioDynamics Reports - Industry Research

Reports Featuring AngioDynamics

Carbonated Beverages Market Major Players

Nephrology Stents And Catheters Market

The nephrology stents and catheters market is valued at USD 1.44 billion in 2023 and is expected to reach USD 2.03 billion by the year 2028, registering a CAGR of 7.10% over the forecast period.

Carbonated Beverages Market Major Players

Global Varicose Veins Treatment Market

The varicose veins treatment market is expected to register a CAGR of 6.0% over the forecast period, 2022-2027.

Carbonated Beverages Market Major Players

Global Ablation Devices Market

The market for ablation devices is expected to grow at a CAGR of 10.4% over the next few years.

Carbonated Beverages Market Major Players

North America Ablation Devices Market

The North America Ablation Devices Market is expected to register a CAGR of nearly 8.5 % during the forecast period.

Carbonated Beverages Market Major Players

Angiography Devices Market

The cardiovascular diseases which include heart attacks, strokes, and other circulatory diseases have become the leading cause of premature deaths.

Carbonated Beverages Market Major Players

Interventional Oncology Devices Market

The interventional oncology devices market is expected to register a CAGR of 8.3% during the forecast period.

Carbonated Beverages Market Major Players

Global Angiographic Catheters Market

The Global Angiographic Catheters market is expected to witness a CAGR of 6.7% during the forecast period.

Carbonated Beverages Market Major Players

Catheter-Directed Thrombolysis Market

The catheter-directed thrombolysis market is expected to grow at a CAGR of 4.2% over the forecast period.

Carbonated Beverages Market Major Players

Clot Management Devices Market

The clot management devices market is expected to register a CAGR of 4.5% over the forecast period.

Carbonated Beverages Market Major Players

Chronic Venous Occlusions Treatment Market

The chronic venous occlusion market is expected to register a CAGR of 9% during the forecast period (2022-2027).

AngioDynamics Competitors